Profil
Krystof S.
Bankiewicz is the founder of Voyager Therapeutics, Inc. (founded in 2013) and Brain Neurotherapy Bio, Inc. (founded in 2018).
At Brain Neurotherapy Bio, Inc., he held the title of Chief Executive Officer from 2018 to 2024.
Currently, Dr. Bankiewicz is the Director-Interventional Neurology Center at The University of California, San Francisco.
Dr. Bankiewicz holds a doctorate degree from Uniwersytet Jagiellonski and Instytut Psychiatrii I Neurologii.
Aktive Positionen von Krystof S. Bankiewicz
| Unternehmen | Position | Beginn |
|---|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Krystof S. Bankiewicz
| Unternehmen | Position | Ende |
|---|---|---|
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Vorstandsvorsitzender | 01.02.2024 |
| VOYAGER THERAPEUTICS, INC. | Gründer | - |
Ausbildung von Krystof S. Bankiewicz
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
The University of California, San Francisco
The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Uniwersytet Jagiellonski
Uniwersytet Jagiellonski Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instytut Psychiatrii I Neurologii
Instytut Psychiatrii I Neurologii Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Brain Neurotherapy Bio, Inc.
Brain Neurotherapy Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Develops transformative neurological gene therapies that restore and preserve health and well-being | Commercial Services |
















